These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 954356)

  • 1. Factors affecting antipyrine metabolism in West African villagers.
    Fraser HS; Bulpitt CJ; Kahn C; Mould G; Mucklow JC; Dollery CT
    Clin Pharmacol Ther; 1976 Sep; 20(3):369-76. PubMed ID: 954356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipyrene clearance in Indian villagers.
    Desai NK; Sheth UK; Mucklow JC; Fraser HS; Bulpitt CJ; Jones SW; Dollery CT
    Br J Clin Pharmacol; 1980 Apr; 9(4):387-94. PubMed ID: 7378255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental effects on antipyrine half-life in man.
    Fraser HS; Mucklow JC; Bulpitt CJ; Khan C; Mould G; Dollery CT
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 2):799-808. PubMed ID: 913037
    [No Abstract]   [Full Text] [Related]  

  • 4. Elimination of antipyrine from saliva as a measure of metabolism in man.
    Welch RM; DeAngelis RL; Wingfield M; Farmer TW
    Clin Pharmacol Ther; 1975 Sep; 18(3):249-58. PubMed ID: 1164815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of cola nut chewing to alter antipyrine disposition in normal male subjects from a small town in South Central Pennsylvania.
    Vesell ES; Shively CA; Passananti GT
    Clin Pharmacol Ther; 1979 Sep; 26(3):287-93. PubMed ID: 466922
    [No Abstract]   [Full Text] [Related]  

  • 6. Salivary antipyrine kinetics in hepatic and renal disease and in patients on anticonvulsant therapy.
    Harman AW; Penhall RK; Priestly BG; Frewin DB; Phillips PJ; Clarkson AR
    Aust N Z J Med; 1977 Aug; 7(4):385-90. PubMed ID: 270989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary antipyrine half-life during injectable progestagen contraception.
    Joshi JV; Gupta KC; Hazari KT; Gokral J; Pohujani S; Satoskar R
    Clin Pharmacokinet; 1986; 11(2):171-5. PubMed ID: 3956050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the half-life of antipyrine in plasma, whole blood and saliva of man.
    van Boxtel CJ; Wilson JT; Lindgren S; Sjöqvist F
    Eur J Clin Pharmacol; 1976 Feb; 9(4):327-32. PubMed ID: 971716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipyrine disposition in milk and saliva of lactating women.
    Berlin CM; Vesell ES
    Clin Pharmacol Ther; 1982 Jan; 31(1):38-44. PubMed ID: 7053302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipyrine metabolism during the menstrual cycle.
    Riester EF; Pantuck EJ; Pantuck CB; Passananti GT; Vesell ES; Conney AH
    Clin Pharmacol Ther; 1980 Sep; 28(3):384-91. PubMed ID: 7408398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipyrine metabolism in man: influence of age, alcohol, caffeine, and smoking.
    Vestal RE; Norris AH; Tobin JD; Cohen BH; Shock NW; Andres R
    Clin Pharmacol Ther; 1975 Oct; 18(4):425-32. PubMed ID: 1164824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced drug metabolism in cigarette smokers.
    Hart P; Farrell GC; Cooksley WG; Powell LW
    Br Med J; 1976 Jul; 2(6028):147-9. PubMed ID: 1276835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saliva and plasma clearance of antipyrine as reflectors of liver function.
    Luoma PV; Sotaniemi EA
    Eur J Drug Metab Pharmacokinet; 1981; 6(4):261-4. PubMed ID: 7333326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urine.
    Vesell ES; Passananti GT; Glenwright PA; Dvorchik BH
    Clin Pharmacol Ther; 1975 Sep; 18(3):259-72. PubMed ID: 1164816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of age and sex on human drug metabolism.
    O'Malley K; Crooks J; Duke E; Stevenson IH
    Br Med J; 1971 Sep; 3(5775):607-9. PubMed ID: 5569980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental factors affecting antipyrine metabolism in London factory and office workers.
    Fraser HS; Mucklow JC; Bulpitt CJ; Kahn C; Mould G; Dollery CT
    Br J Clin Pharmacol; 1979 Mar; 7(3):237-43. PubMed ID: 427001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition of antipyrine and phenytoin correlated with age and liver volume in man.
    Bach B; Hansen JM; Kampmann JP; Rasmussen SN; Skovsted L
    Clin Pharmacokinet; 1981; 6(5):389-96. PubMed ID: 7333060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipyrin clearance in homozygous beta-thalassemia.
    Rifkind AB; Canale V; New MI
    Clin Pharmacol Ther; 1976 Oct; 20(4):476-83. PubMed ID: 975719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of fever on antipyrine metabolism in children.
    Forsyth JS; Moreland TA; Rylance GW
    Br J Clin Pharmacol; 1982 Jun; 13(6):811-5. PubMed ID: 7093111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of antipyrine pharmacokinetics in saliva and plasma using a colourimetric method of antipyrine analysis.
    Harman AE; Priestly BG; Frewin DB
    Clin Exp Pharmacol Physiol; 1977; 4(6):593-6. PubMed ID: 589875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.